Boehringer ends development of Alzheimer’s candidate

12th February 2018 Uncategorised 0

Boehringer Ingelheim is ending development of BI 409306 in Alzheimer’s disease on disappointing mid-stage trial data.

More: Boehringer ends development of Alzheimer’s candidate
Source: News